Polyoxometalate complexes and uses in managing cancer
US11331297B2 · kind B2 · utility
1Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2017 |
| Grant date | May 17, 2022 |
| Priority date | — |
| Expiry date | Oct 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09D7/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates polyoxometalate complexes and uses in the management, treatment, or prevention of cancer. In certain embodiments, the polyoxometalate complexes comprise polydentate oxygen bridging ligands such as those of the following formula: [POM{(OCH2)3CX}2], [M6O13{(OCH2)3CX}2], [V6O13 {(OCH2)3CX}2], salts, or derivatives thereof wherein POM is a polyoxometalate, M is a metal, and X is defined herein. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising polyoxometalate complexes disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.